Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This New Study Could Give Moderna a Big Advantage in 2022
This New Study Could Give Moderna a Big Advantage in 2022
This New Study Could Give Moderna a Big Advantage in 2022
Submitted by
admin
on December 18, 2021 - 10:46pm
Source:
Motley Fool
News Tags:
Moderna Therapeutics
Pfizer
AstraZeneca
COVID-19
vaccines
boosters
Headline:
This New Study Could Give Moderna a Big Advantage in 2022
snippet:
Moderna's booster shot could be an optimal choice, even for people who previously took Pfizer's vaccine.
The new omicron variant could accelerate the pace of booster shots.
An increase in demand could set up the company to outperform next year.
Do Not Allow Advertisers to Use My Personal information
